Yitzhak Peterburg

Teva's Interim President & CEO since February 2017, Served as Chairman of Teva's Board between 2015-2017. On Teva’s Board since 2012 and between 2009-2010. Previously Group VP—Global Branded Products. Served as President and CEO of Cellcom Israel, Director General of Clalit Health Services, and CEO of Soroka University Medical Center. Board director of Rosetta Genomics, Chairman of Regenera Pharma Ltd. M.D.- Hadassah Medical School, Health Administration PhD- Columbia University, Information Systems M.Sc.- London School of Economics.